ProCom One, Inc.

12 patents currently held · Updated Nov 14, 2026

5 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

May 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 14, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,486,437	Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 9,801,847	Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 9,861,607	Methods of Using Low-Dose Doxepin for the Improvement of Sleep In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 10,143,676	Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 10,238,620	Methods of Using Low-Dose Doxepin for the Improvement of Sleep In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 10,251,859	Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 10,493,053	Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 10,653,662	Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 10,758,510	Doxepin Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence
US 11,007,168	Doxepin Trans Isomers And Isomeric Mixtures And Methods Of Using The Same To Treat Sleep Disorders In force Term ends May 18, 2027 · Medium confidence	In force	Term ends May 18, 2027	Medium confidence

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Also on record, not counted in the 12: 5 patents in force now held by others · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 3 abandoned · 2 no status recorded

List them